Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Engineering Immunomodulatory Biomaterials for Regenerating the Infarcted Myocardium

Frontiers in Bioengineering and Biotechnology(2020)10.3389/fbioe.2020.00292Source: DataRank Database

Engineering Immunomodulatory Biomaterials for Regenerating the Infarcted Myocardium is a research paper published in Frontiers in Bioengineering and Biotechnology (2020). On theSindex it has a DataRank of 0. It has been cited 47 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access47 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 6.66)OA: goldTopics (41)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Isobel Rountree,Collin Polucha,Giulia Montagna ORCID,Livia Visai ORCID,Kareen L. K. Coulombe ORCID

Live enrichment

PubMed:32318563 PMC:PMC7154131 OpenAlex:https://openalex.org/W3016039176

NHLBI NIH HHS

Grant: R01 HL135091

National Institutes of Health

Grant: 5R01HL135091-03

Engineering Human Myocardium with Hybrid Biomaterials for Heart Regeneration

FWCI

6.66

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.3389/fbioe.2020.00292

publisherhttps://doi.org/10.3389/fbioe.2020.00292

publisherhttps://www.frontiersin.org/article/10.3389/fbioe.2020.00292/full

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32318563

repositoryhttps://doaj.org/article/c258e407b9f24328b8ac3944f5d29c66

Fields of Study

Tissue Engineering and Regenerative MedicineCardiac Ischemia and ReperfusionCardiac Fibrosis and Remodeling0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

In vivoMedicineWound healingAngiogenesisIschemiaTherapeutic angiogenesisCell therapySelf-healing hydrogelsTissue engineeringNeovascularizationImmune systemInflammationPharmacologyBiomedical engineeringCancer researchImmunologyCardiologyStem cellCell biologyChemistryBiologyMacrophagesCytokinesMyocardial infarctRevascularizationBiomaterialsImmune Engineeringbiomaterialangiogenesi610Bioengineering and BiotechnologymacrophagecytokineTP248.13-248.65Biotechnology

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being